WuXi Biology and Testing Experts
Meet the peer-recognized scientists, toxicologists, and drug discovery specialists driving global innovation at WuXi Biology and Testing.
Meet Our Teams
WuXi Biology and Testing’s global network of seasoned scientific and regulatory experts brings decades of hands-on experience executing successful preclinical and clinical programs across major international markets. Wherever your development path leads, our worldwide teams work in tandem to deliver local insight, seamless cross-border collaboration, and the rigorous data required to advance your therapeutics globally.
Discovery Biology
Our dedicated Biology team combines deep scientific expertise with state-of-the-art platforms to accelerate your early-stage drug development pipeline. From target identification to lead optimization, we partner closely with you to advance promising therapeutics with confidence.
Executive Director of DEL Platform, Crelux Managing Director DEL, OBOC, D2B, MedChem, Other Screening Methods, Molecular Glue Degrader, PROTAC, Peptides
Basel, CH
Head of Oligonucleotide Drug Discovery Platform Oligonucleotide, Oligo Conjugates, Cellular Assay, In Silico Drug Design, Metabolic Disease
Shanghai Waigaoqiao, CN, Shanghai Zhangjiang, CN
Scientific Director ADC Discovery Other Target Classes, Monoclonal Antibodies, Multi-specific Antibodies, ADC, CAR-T & Other CGT, Cellular Assay, In Vivo Pharmacology, Oncology, Immunology, Autoimmune Disease
Singapore
Scientific Director for Metabolic Diseases, Oligo Conjugates, GPCRs, Conventional Small Molecules, Metabolic Disease, Ion Channels
Copenhagen, DK
Executive Director, WuXi Biology San Diego Site Head Conventional Small Molecules, RNA-Targeting Small Molecules, Other Small Molecule Drugs, Molecular Glue Degrader, Other Proximity-Induced Modifiers, Target Discovery, Target Validation, HTS/HCS, Oncology, Immunology, Inflammatory Disease, Autoimmune Disease, Cellular Assay, Biochemical Assay
California, USA
Senior Director Integrated Drug Discovery CAR-T & Other CGT, Vaccine, Cellular Assay, In Vivo Pharmacology, Animal Model, Oncology, Immunology, Autoimmune Disease, Infectious Disease, Inflammatory Disease, Other Target Classes, Multispecific Antibodies, Monoclonal Antibodies, Biochemical Assay
Oxford, UK
Head of In Vitro Neuroscience Ion Channels, Other Target Classes, RNA-Targeting Small Molecules, Oligonucleotide, Oligo Conjugates, Target Discovery, Target Validation, Biochemical Assay, Biophysical Assay, Cellular Assay, Biomarker, Drug Delivery, Organoid, Organ-On-Chip, Neurology, Neuropsychiatry, GPCRs
Shanghai Waigaoqiao, CN
Project Director - Integrated Drug Discovery Team Neurology, Conventional Small Molecules, HTS/HCS, Biochemical Assay, Cellular Assay
Belgium, EU
Head of Vital Organ Pharmacology Center Metabolic Disease, Cardiovascular Disease, Endocrinology, Hepatobiliary Disease, Women's Health
Shanghai Waigaoqiao, CN
Head of Peptide Discovery mRNA Display, DEL, Phage Display, Peptides
Massachusetts, USA
Executive Director Integrated Drug Discovery Oligonucleotide, Conventional Small Molecules, Cardiovascular Disease, Metabolic Disease
New Jersey/New York, USA
Head of Autoimmune, Inflammatory, and Infectious Disease Platform In Vivo Pharmacology, Immunology, Inflammatory Disease, Autoimmune Disease
Shanghai Waigaoqiao, CN
Scientific Director of Oligonucleotides Therapeutics Platform and Ophthalmology Oligonucleotide, Oligo Conjugates, Target Discovery, Target Validation, Ion Channels, Pulmonary and Respiratory Disease, Sensory Disease
California, USA
Toxicology
Our Toxicology team delivers robust data to meet your critical milestones, keeping innovative small molecules and advanced biologics on the path to success. We partner with you to design a tailored program addressing your specific safety and development needs.
Executive Technical Director
Munich, DE
Senior Technical Director
Washington, USA
Executive Technical Director
Toronto, Ontario, CA
Executive Technical Director
North Carolina, USA
DMPK
Our DMPK team integrates early ADME studies into your discovery process to optimize PK parameters, enhance efficacy, and mitigate drug-drug interaction risks. By aligning preclinical insights from early screening through pre-first-in-human evaluations, we provide robust data to validate safety assessments and help prevent compound failure.
Senior Advisor, DMPK
Basel, SW
Associate Director, DMPK
New Jersey, USA
Technical Director, DMPK
New Jersey, USA
Bioanalysis
Our global bioanalytical team leverages advanced technology platforms and regulatory expertise to deliver comprehensive support from discovery through clinical phases. We tailor our approach to generate the robust data required for your submissions.
Director, Bioanalytical Services
Shanghai, CN
Senior Director, Preclinical Bioanalysis
Suzhou, CN
Executive Director, Bioanalytical Services
Shanghai, CN
Senior Director, Head of BAS biomarker platform
Shanghai, CN
Principal Scientist
Suzhou, CN
Principal Scientist
Suzhou, CN
Director, Preclinical Bioanalytical Services
Suzhou, CN
Vice President, Bioanalytical Services
Shanghai, CN
Senior Principal Scientist
Suzhou, CN
Director, Bioanalytical Services
Shanghai, CN
Associate Director, Bioanalytical Services
Shanghai, CN
Discuss Your Program with Us
Share your development goals and key challenges with our experts to define the right path forward.